Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiovascular Diseases 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1

Interventions

Exercise 5 Omeprazole 3 Etanercept 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Resistance Training 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Dexmedetomidine 2 Colchicine 2 Aspirin 2 Ascorbic Acid 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dolutegravir 1 dapagliflozin 1 cytisine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01821404 2018-05-07

ESTO1

Tampere University Hospital

Phase 2 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡